PULMATRIX, INC. Property, Plant and Equipment, Gross
PULMATRIX, INC. (PULM) had Property, Plant and Equipment, Gross of $2.90 million as of 2024-03-31, per its 10-Q filed 2024-05-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2025-03-21
- 2024-03-31: Property, Plant and Equipment, Gross $2.90M.
- 2023-12-31: Property, Plant and Equipment, Gross $2.89M.
- 2023-09-30: Property, Plant and Equipment, Gross $2.86M.
- 2023-06-30: Property, Plant and Equipment, Gross $3.08M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2024-03-31 | $2.90M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $2.89M 10-K · filed 2025-03-21 |
| 2023-09-30 | $2.86M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $3.08M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $2.98M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $2.98M 10-K · filed 2024-03-28 |
| 2022-09-30 | $3.02M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $3.02M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $2.99M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $2.96M 10-K · filed 2023-03-30 |
| 2021-09-30 | $2.95M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $2.95M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $2.86M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $2.84M 10-K · filed 2022-03-29 |
| 2019-12-31 | $2.56M 10-K · filed 2021-03-23 |
| 2019-09-30 | $2.55M 10-Q · filed 2019-11-01 |
| 2019-06-30 | $2.54M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $2.52M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $2.51M 10-K · filed 2020-03-26 |
| 2017-12-31 | $3.48M 10-K · filed 2019-02-19 |
| 2016-12-31 | $3.46M 10-K · filed 2018-03-13 |
| 2015-12-31 | $3.29M 10-K · filed 2017-03-10 |
| 2015-03-31 | $160.00K 10-K · filed 2015-06-10 |
| 2014-12-31 | $3.00M 10-K · filed 2016-03-10 |
| 2014-03-31 | $4.00K 10-K · filed 2015-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |